HighLife plans to prioritise procedural consistency and imaging-guided follow-up for safety in early commercial settings.

HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.

HighLife Receives CE Mark Approval for its TMVR SolutionParis, January 26, 2026 – HighLife SAS, a leading MedTech company focused on ...

DENVER, CO — Two cardiac valve prostheses, similar in capability, offer the prospect of significant relief of mitral regurgitation (MR) via transcatheter mitral-valve replacement (TMVR) for patients ...

VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of ...

NEW YORK CITY -- Mitral valve technology developers were urged to go back to the drawing board due to current-generation devices not meeting the needs of enough patients with mitral regurgitation (MR) ...

Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A transapical transcatheter mitral valve repair system ...

Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...

BALTIMORE, MD — Transcatheter mitral-valve repair (TMVR) is to be covered under Medicare for the treatment of significant symptomatic degenerative mitral regurgitation (MR), the Centers for Medicare & ...